A new real-world study found that Comprehensive Genomic Profiling (CGP) leads to better personalized treatment and patient outcomes when done early in a cancer diagnosis. CGP-assessed patients received biomarker-driven targeted therapy or immunotherapy, significantly improving overall survival of 25 months compared to chemotherapy alone.
The MedPearl platform improved primary care clinician productivity, decreasing time waste on administrative tasks and enhancing the quality of referrals to specialists. Clinician users reported a 72% improvement in clinical management and workups, with a high user retention rate after system-wide integration.
Researchers found that non-lung transplant recipients from positive donors have excellent 30-day graft and patient survival rates, similar to those using donors negative for SARS-CoV-2. The study also showed zero transmissions of COVID-19 to lung transplant recipients after implementing lower respiratory track testing.
A study reveals a high incidence of chronic kidney disease among adults with diabetes, particularly affecting Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino(a) groups. The rate of new onset CKD was higher in these groups by approximately 60%, 40%, 33%, and 25% compared to White persons with ...
A Providence study found that booster doses of an mRNA vaccine add about 70% extra protection for 4-5 months, resulting in a significant decrease in hospitalization rates. Boosters are associated with decreased odds of severe COVID-19 among fully vaccinated individuals.
A study found that prior symptomatic COVID-19 infection provided a similar degree of protection against reinfection as mRNA vaccination, with natural immunity offering a longer window of protection.
A Providence study confirms COVID vaccines are 94% effective at preventing hospitalization within 50-100 days of vaccination, but protection declines to 80.4% after 200-250 days. The study also identifies key risk factors for severe breakthrough infections, including advanced age, comorbidities, and vaccine type.